The Kinghorn Cancer Centre /ID# 225248
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Christophersen, Louise
NCT04202835: ATG Plus PTCy vs ATG for CGVHD Prophylaxis

Recruiting
2
80
Canada, RoW
Cyclophosphamide, Anti-Thymocyte globulin (rabbit), Thymoglobulin
McMaster University, Cell Therapy Transplant Canada, Sanofi, Ozmosis Research Inc.
Acute Leukemia, Myelodysplasia, Chronic Graft-versus-host-disease
10/24
12/24
NKX019-101, NCT05020678: NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

Active, not recruiting
1
150
US, RoW
NKX019
Nkarta, Inc.
Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma, Waldenstrom Macroglobulinemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Aggressive Lymphoma, Large-cell Lymphoma
03/25
12/38

Download Options